16 May 2020
4QFY20 Results Update | Sector: Financials
Mahindra & Mahindra Financial
Estimate change
TP change
Rating change
Bloomberg
Equity Shares (m)
M.Cap.(INRb)/(USDb)
52-Week Range (INR)
1, 6, 12 Rel. Per (%)
12M Avg Val (INR M)
Financials & valuations (INR b)
Y/E March
2020 2021E
NII
PPP
PAT
EPS (INR)
EPS Gr. (%)
BV/Sh.(INR)
Ratios
NIM (%)
C/I ratio (%)
RoA (%)
RoE (%)
Payout (%)
Valuations
P/E (x)
P/BV (x)
Div. Yield (%)
51.1
34.0
9.1
14.7
-41.8
185
8.3
37.3
1.3
8.3
0.0
11.4
0.9
0.0
46.1
31.3
4.9
8.0
-46.0
193
7.4
36.6
0.7
4.2
23.4
21.1
0.9
0.0
MMFS IN
615
104 / 1.4
439 / 128
6/-25/-39
898
CMP: INR168
TP: INR 200 (+19%)
Provisioning cost partly offset by controlled opex
Buy
2022E
49.3
33.1
8.8
14.3
80.0
204
8.2
37.5
1.2
7.2
23.4
11.7
0.8
1.7
MMFS 4QFY20 PAT of INR2.2b (down 62% YoY), a 40% miss. The miss in
PAT was led by a contingency provision of INR5.7b (we factored in
~INR2.2b) related to COVID-19. Of INR5.7b, INR4.7b was used to increase
PCR (800bps QoQ to 31%) for GNPA. Pre-provisioning profits grew 24% YoY
(beat of 14%) to INR9.7b as opex (27% beat) declined 24% YoY to INR4.2b.
Net income missed our estimate by 3% as loans stood largely flat QoQ
(+6% YoY) at INR650b v/s the expectation of ~2% QoQ growth (on March-
end COVID-19 restrictions). NIMs/GS3% came in flat QoQ at 7.7%/8.4%.
Restrictions imposed on the movement of goods and people due to
COVID-19 would have a significant impact on growth and asset quality. We
have cut estimates by 22%/4% for FY21/FY22. ROEs are likely to be less
than 10% over FY20–22. While a valuation at 0.8x FY22 BV is comfortable,
considerable relaxation in lockdown restriction remains a key catalyst.
The value of assets financed declined 28% YoY to INR93b. While decline
was witnessed across products, the CV and CE segments (40%+ sequential
declines) led the laggards. The AUM mix was largely stable (Exhibit 3).
Gross Stage 3 asset were flat QoQ at ~INR57b. Weighed by challenging
macros, MMFS increased PCR levels to 31% (+800bp QoQ) on GNPA.
ECL% has increased to 4.4% v/s 3.6%in 3QFY20 and 2.9% in 4QFY19.
MMFS has already commenced operations at 500 of its 1320+ branches;
200+ branches would resume shop shortly. However, operations in North
(29% of AUM)/West (15%) have resumed only in 28%/34% locations.
MMFS is comfortable on the ALM front, with liability repayments of
INR21b/INR34b in May/June 2020 and 2QFY20, against a cash balance of
INR45b, in addition to undrawn sanctions.
75%+ customers availed moratorium. Those who chose not to avail it
belong largely to the farming community. Collection efficiency stood at
15–16% in April.
8–9 areas were identified where opex could be reduced by ~50bp in FY21.
Customers are not expected to surrender their assets. A delay, but not a
default, is likely.
We have baked in a 40% drop in disbursements in FY21 as 1H is likely to
see a plunge (60–70%); we expect healthy, but gradual recovery from
2HFY21. With a higher share (75%) of moratorium availed and collections
issues, repayment rates are likely to be lower and thus support AUM.
Forecasting asset quality and credit cost is challenging as they are likely to
be guided by the easing of restrictions on COVID-19. The Red zone
contributes ~30% to AUM. We have baked in ~3.9% credit cost v/s 2.35%
in FY20 (ex-contingency provisions).
We have baked in a sharp drop of ~100bp in NIMs in FY21 due to
challenging asset quality. A valuation of 0.8x PBV largely factors in near-
term issues. Recovery/upgrades are likely to be the quickest as restrictions
ease, as the underlying customer base’s cashflows, especially in the
Farming segment, are healthy.
Buy.
Loan growth moderates and asset quality stands stable QoQ
Comfortable on liquidity; Gradual resumption of operations
Shareholding pattern (%)
As On
Mar-20 Dec-19
Promoter
51.2
51.2
DII
15.6
15.4
FII
24.3
25.3
Others
8.9
8.2
FII Includes depository receipts
Mar-19
51.2
13.6
27.2
7.9
Highlights from management commentary
Valuation and view
Research Analyst: Alpesh Mehta
(Alpesh.Mehta@MotilalOswal.com);+91 22 6129 1526 |
Piran Engineer
(Piran.Engineer@MotilalOswal.com); +91 22 6129 1539
Nitin Aggarwal
(Nitin.Aggarwal@MotilalOswal.com); +91 22 6129 1542 |
Divya Maheshwari
(Divya.Maheshwari@motilaloswal.com); +91 22 6129 1540
14
Oswal
2020
1
Motilal
January
research is available on www.motilaloswal.com/Institutional-Equities, Bloomberg, Thomson Reuters, Factset and S&P Capital.
Investors are advised to refer through important disclosures made at the last page of the Research Report.